The latest immunotherapy news and developments
Two studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of…
The advent of immune checkpoint inhibitors – which “release the brakes” of the body’s immune…
A combination of the experimental histone deacetylase (HDAC) inhibitor entinostat with the anti-PD-1 therapeutic pembrolizumab…
The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumour activity with durable responses in patients…
Melanomas tend to be ‘hot’ or ‘cold’ – if they’re hot, immunotherapy lights melanoma tumours…
A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumours to shrink in…
A preclinical study led by scientists at the UCLA Jonsson Comprehensive Cancer suggests that heating…
White blood cells known as B cells have been shown to be effective for predicting…
NASCAR has nothing on cancer cells when it comes to exploiting the power of drafting,…
Researchers have identified a biomarker and a possible new therapy for melanoma. Their findings have…